MARY TOMPKINS: Open Payments
NPI 1396274445 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 20 payments from 11 companies in 2025. Trend: 2023 $115 · 2024 $0 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| Antares Pharma, Inc. | 4 | $86 |
| Merck Sharp & Dohme LLC | 3 | $73 |
| Alnylam Pharmaceuticals Inc. | 3 | $61 |
| Janssen Biotech, Inc. | 2 | $54 |
| TOLMAR, INC. | 2 | $48 |
| UROGEN PHARMA, INC. | 1 | $36 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| 180 Medical, Inc. | 1 | $29 |
| Endo USA, Inc. | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $23 |
Products named: XYOSTED, GIVLAARI, ERLEADA, JATENZO, KEYTRUDA, JELMYTO, PROVENGE, LYNPARZA.
Industry payments across NY — which companies pay providers there.
